Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 233

MIT engineers uncover a surprising reason why tissues are flexible or rigid

Water makes up around 60 percent of the human body. More than half of this water sloshes around inside the cells that make up organs and tissues. Much of the remaining water flows in the nooks and crannies between cells, much like seawater between grains of sand.

Now, MIT engineers have found that this “intercellular” fluid plays a major role in how tissues respond when squeezed, pressed, or physically deformed. Their findings could help scientists understand how cells, tissues, and organs physically adapt to conditions such as aging, cancer, diabetes, and certain neuromuscular diseases.

In a paper appearing today in Nature Physics, the researchers show that when a tissue is pressed or squeezed, it is more compliant and relaxes more quickly when the fluid between its cells flows easily. When the cells are packed together and there is less room for intercellular flow, the tissue as a whole is stiffer and resists being pressed or squeezed.

New carbon material sharpens proton beams, potentially boosting cancer treatment precision

Researchers from the National University of Singapore (NUS) have developed a groundbreaking carbon membrane that could revolutionise proton therapy for cancer patients, and advance technologies in medicine and other areas such as energy devices and flexible electronics.

The new carbon material which is just a single atom thick shows incredible promise in enabling high-precision proton beams. Such beams are key to safer and more accurate proton therapy for cancer treatment. The new material, called the ultra-clean monolayer amorphous carbon (UC-MAC), could outperform best in class materials like graphene or commercial carbon films.

The research was led by Associate Professor Lu Jiong and his team from the NUS Department of Chemistry, in collaboration with international partners.

New Technique Uses Focused Sound Waves and Holograms to Control Brain Circuits

NEW YORK, Aug. 5, 2025 /PRNewswire/ — A new study provides the first visual evidence showing that brain circuits in living animals can be activated by ultrasound waves projected into specific patterns (holograms).

Led by scientists at NYU Langone Health and at the University of Zurich and ETH Zurich in Switzerland, the study describes a system that combines sources of ultrasound waves and a fiber scope connected to a camera to visualize in study mice brain targets that are directly activated by the sound. This lays the groundwork, the study authors say, for a new way to treat neurological diseases and mental health disorders from outside of the body.

Already, there are applications approved by the Food and Drug Administration and designed to reduce tremor symptoms seen in Parkinson’s disease, using intense sound waves to kill brain cells called neurons within neural pathways linked to tremors. Rather than kill neurons, the lower-intensity ultrasound waves used in the current work can temporarily activate them, the researchers say. The resulting effects can be widespread as neurons relay messages to other neurons within their circuits and between interconnected neuronal circuits.

Metabolic signals in neurons determine whether axons degrade or resist neurodegeneration, study finds

Unlike most cells in the human body, neurons—the functional cells of our nervous system—cannot typically replace themselves with healthy copies after being damaged.

Rather, after an injury from something like a stroke, concussion or neurodegenerative disease, neurons and their axons, fiber-like projections that relay , are far more likely to degrade than regenerate.

But new research from the University of Michigan opens new ways to think about neurodegeneration that could help protect patients against that degradation and neurological decline in the future.

Stem cells created from ALS patients point to potential new target for treatment

Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig’s disease, is an incurable neurological disorder affecting motor neurons—nerve cells in the brain and spinal cord that control voluntary muscle movement and breathing.

Many ALS , including those testing promising drugs, have fallen short of expectations—often because the extent of the disease can vary, and patients don’t respond the same way to medications.

But a new study led by scientists at Case Western Reserve University used created from ALS patients to target a specific gene as a kind of shut-off valve for what stresses —and it worked.

Discovery of a new analgesic promises pain relief with fewer downsides

Opioids like morphine are widely used in medical practice due to their powerful pain-relieving effects, yet they carry the risk of serious adverse effects such as respiratory depression and drug dependence. For this reason, Japan has strict regulations in place to ensure that these medications are prescribed only by authorized physicians.

In the United States, the opioid OxyContin was once frequently prescribed, triggering a surge in the misuse of synthetic opioids such as fentanyl. As a result, the number of deaths caused by surpassed 80,000 in 2023, escalating into a national public health crisis now referred to as the “opioid crisis.”

Opioids may soon have a rival, however. A team of researchers at Kyoto University has recently discovered a novel analgesic, or , that exerts its effect through an entirely different mechanism. Clinical development of their drug ADRIANA is currently underway as part of an international collaborative effort.

Imaging provides indicators for early detection of depression, paths for future prevention and treatment efforts

Novel imaging research indicates that young adults with a higher genetic risk for depression showed less brain activity in several areas when responding to rewards and punishments. The study also uncovered notable differences between men and women.

The findings from this new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, highlight potential early indicators for depression before clinical symptoms fully manifest.

Depression is one of the most common mental health conditions, and many people with depression have trouble processing rewards and punishments.

Startup founder cuts his legs to demonstrate a new biotechnology — investors give him $4.3 million

Jake Adler, the 21-year-old founder of the biotech and defense startup Pilgrim, literally put his own sweat and blood into developing the business, cutting his thighs to demonstrate the new technology. Surprisingly, this bloody effort paid off and he received $4.3 million from investors.

Pilgrim creates biotechnology for use on the battlefield, with plans to sell to the military and eventually civilians. Their flagship product is the Kingsfoil hemostatic bandage, which startup CEO Jake Adler cut both of his legs on camera to demonstrate.

We won’t publish the video and will avoid giving details. In short: Adler anesthetized his legs with lidocaine and used a biopsy tool to make two precise cuts. One of them was covered with Kingsfoil to stop the bleeding, and the other was used for a control comparison.

/* */